Position in ZTS
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$280,394
-$175,326 QoQ
Shares Held
2,372
-34.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Prime Capital Investment Advisors, LLC holds $767,683 across 2 Drug Manufacturers - Specialty & Generic names.
All Filings in ZTS
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $280,394 | 2,372 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $455,720 | 3,622 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $7,759,788 | 53,033 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $7,829,469 | 50,205 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $13,894,813 | 84,390 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,609,911 | 9,881 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $7,525,646 | 38,518 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $6,576,931 | 37,938 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,529,827 | 9,041 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $960,797 | 4,868 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $1,820,874 | 10,466 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,684,213 | 9,780 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,403,422 | 8,432 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $312,591 | 2,133 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $280,564 | 1,892 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $234,801 | 1,366 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||